News
-
-
-
COMMUNIQUÉ DE PRESSE
Press release: Sanofi successfully prices €1.5 billion bond issue
Sanofi successfully prices €1.5 billion bond issue with fixed-rate notes across 2 tranches, using proceeds for general corporate purposes, led by Citigroup and RBC Capital Markets, under Euro Medium Term Note Programme -
-
COMMUNIQUÉ DE PRESSE
Sanofi : Déclaration des transactions sur actions propres
-
COMMUNIQUÉ DE PRESSE
Sanofi: Disclosure of trading in own shares
-
-
-
COMMUNIQUÉ DE PRESSE
Press Release: EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal polyps in patients with coexisting asthma in first-ever presented phase 4 head-to-head respiratory study
Dupixent outperformed Xolair in treating chronic rhinosinusitis with nasal polyps and coexisting asthma, showing superior efficacy across all key endpoints in a phase 4 study presented at EAACI -
